|

Siponimod Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since June 2026

Also known as: Mayzent

Pipeline

Phase 2: 1

Top Sponsors

  • St. Joseph's Hospital and Medical Center, Phoenix1

Indications

  • MCI With Increased Risk for Alzheimer Disease1
  • Mild Alzheimer Disease1
  • Alzheimer's Disease1
  • Cognitive Impairment, Mild1
  • Alzheimer Disease1

Phoenix, Arizona1 trial

Repurposing Siponimod for Alzheimer's Disease

St. Joseph's Hospital and Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.